Merck

YTD

ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO

Robert M. Davis

CEORobert M. Davis

Employees

75,000

Employees75,000

Headquarters

Rahway, New Jersey

HeadquartersRahway, New Jersey

Founded

1891

Founded1891

Employees

75,000

Employees75,000

MRK Key Statistics

Market cap

293.27B

Market cap293.27B

Price-Earnings ratio

33.41

Price-Earnings ratio33.41

Dividend yield

2.80%

Dividend yield2.80%

Average volume

10.00M

Average volume10.00M

High today

$120.67

High today$120.67

Low today

$118.19

Low today$118.19

Open price

$119.76

Open price$119.76

Volume

16.60M

Volume16.60M

52 Week high

$125.14

52 Week high$125.14

52 Week low

$75.40

52 Week low$75.40

Stock Snapshot

Merck(MRK) stock is priced at $118.51, giving the company a market capitalization of 293.27B. It carries a P/E multiple of 33.41 and pays a dividend yield of 2.8%.

On 2026-05-30, Merck(MRK) stock moved within a range of $118.19 to $120.67. With shares now at $118.51, the stock is trading +0.3% above its intraday low and -1.8% below the session's peak.

Trading volume for Merck(MRK) stock has reached 16.6M, versus its average volume of 10M.

The stock's 52-week range extends from a low of $75.40 to a high of $125.14.

MRK News

Investing.com 13h

Jefferies starts Merck KGaA at Hold, sees limited upside - Investing.com

...

TipRanks 1d

Merck says FDA grants Breakthrough Therapy Designation for calderasib

Merck (MRK) announced that calderasib, an investigational oral specific KRAS G12C inhibitor, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, has been g...

TipRanks 2d

Merck Shareholders Back Board, Pay and Auditor Ratification

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

70%

of 30 ratings

Buy

70%

Hold

30%

Sell

More MRK News

Nasdaq 2d

Here is What to Know Beyond Why Merck & Co., Inc. is a Trending Stock

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near...

Simply Wall St 3d

Merck’s Expanding Oncology Suite And Fresh Debt Raise Might Change The Case For Investing In MRK

In May 2026, Merck & Co., Inc. received a positive CHMP opinion backing KEYTRUDA plus Padcev for certain bladder cancer patients in Europe and reported successf...

Simply Wall St 4d

Merck Faces Talc Verdict Questions For Future Legal And Earnings Risks

Minnesota jury issues a $10.2 million mesothelioma verdict linked to asbestos in talc products. Merck (NYSE:MRK) is named as a co-defendant through historical...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Flowserve

ResMed

SPDR EURO STOXX 50 ETF

Cognex

WisdomTree Japan Hedged E…

Baker Hughes Company

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.